PlainPharmaWatch

CMS Open Payments · Tool

Banner Life Sciences, LLC vs Mitsubishi Tanabe Pharma Corporation

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Mitsubishi Tanabe Pharma Corporation has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 1,705, versus 487 for the other company. Its single largest recorded recipient represents 0.2% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Banner Life Sciences, LLC
HHI 487 · top recipient 0.2%
Ranked #1,297 of 1,838 companies by HHI
Mitsubishi Tanabe Pharma Corporation
HHI 1,705 · top recipient 0.2%
Ranked #813 of 1,838 companies by HHI

Payment Overview

Total Payments
$92.8K
% of Industry
0.0%
Transactions
2,050
Avg per Transaction
$45.25
Recipients
2,044
Avg per Recipient
$45.38
Payment Types
3
Top Payment Type
Food and Beverage
Total Payments
$92.7K
% of Industry
0.0%
Transactions
45
Avg per Transaction
$2.1K
Recipients
45
Avg per Recipient
$2.1K
Payment Types
3
Top Payment Type
Travel and Lodging

Highlighted values indicate the higher figure for each metric.

Total payments compared

Banner Life Sciences, LLC vs Mitsubishi Tanabe Pharma Corporation - total reported payments in CMS Open Payments PY2024

Banner Life Sciences, LLC$92.8KMitsubishi Tanabe Pharma Co…$92.7K

Payment Types Breakdown

Banner Life Sciences, LLC

Food and Beverage $42.7K

46.0%

Compensation for Services Other Than Consulting $34.7K

37.4%

Space Rental or Facility Fees $5.0K

5.4%

Mitsubishi Tanabe Pharma Corporation

Travel and Lodging $65.6K

70.8%

Compensation for Services Other Than Consulting $26.4K

28.4%

Food and Beverage $739.71

0.8%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Banner Life Sciences, LLC

  1. 1

    REBECCA JONES

    $13,938.79 · 35 txns

  2. 2

    AJO JOY

    $7,106.94 · 6 txns

  3. 3

    SANGJIN OH

    $5,012.55 · 25 txns

  4. 4

    VANDERBILT UNIVERSITY MEDICAL CENTER

    $5,000.00 · 1 txns

  5. 5

    MARY ANN PICONE

    $4,680.41 · 5 txns

Mitsubishi Tanabe Pharma Corporation

  1. 1

    JEFFREY BENNETT

    $20,751.83 · 6 txns

  2. 2

    MARIA DELAS MERCEDES PEREZ RODRIGUEZ

    $17,856.79 · 7 txns

  3. 3

    DANIEL PODOLSKY

    $17,462.90 · 4 txns

  4. 4

    BRUCE SANDS

    $15,657.49 · 8 txns

  5. 5

    NILAY S SETHI

    $10,510.24 · 6 txns

Summary Comparison

Metric Banner Life Sciences, LLC Mitsubishi Tanabe Pharma Corporation
Total Payments $92.8K $92.7K
% of Industry Total 0.0% 0.0%
Transaction Count 2,050 45
Avg per Transaction $45.25 $2.1K
Recipient Count 2,044 45
Avg per Recipient $45.38 $2.1K
Payment Type Count 3 3
Top Payment Type Food and Beverage Travel and Lodging

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.